Navigation Links
Further Evidence that the PhotoActivation of PRP (PAPRP) is a Novel and Effective Treatment for Osteoarthritis and Knee Pain
Date:7/21/2013

Melbourne, Australia (PRWEB) July 22, 2013

A 40 Patient Clinical Trial using AdiStem PRP PhotoActivation is being planned in Australia following two initial case studies published in the “British Medical Journal”. One was on a 50 year old woman in Melbourne with left knee osteoarthritis and the other on a 38 year old man with traumatic chondral lesion of the left knee.

The 50 year old woman had progressive and symptomatic left knee osteoarthritis and recently received treatment where her knee was injected with PhotoActivated Platelet Rich Plasma (PAPRP). Following treatment her Numerical Pain Rating Scale (NPRS) improved at Week 1 suggesting an immediate anti-inflammatory and analgesic benefit of PAPRP. At 18 weeks following the initial PAPRP injection, the patient reported a perceived improvement of 80% in both pain and function as measured by NPRS and WOMAC. No complications were noted.

The use of PRP has been expanding rapidly. Platelets contain an abundance of growth factors, cytokines and bioactive molecules crucial to hard and soft tissue healing and leading to a significant reduction in pain. It is now recognized that the additional use of low intensity light at specific frequencies increases both the release of anti-inflammatory agents and beta endorphins -- the bodies natural pain reliever -- which contributes to the patient’s comfort.

During the procedure, the patients’ autologous blood is centrifuged for 10 minutes. This yields plasma which is then withdrawn into a sterile tube and exposed to photoactivation for 10 minutes using the AdiLight-2 device from AdiStem Ltd, Hong Kong. The resulting PAPRP is then injected into the knee. The process should be repeated 3 times – 1 week apart. (BMJ Case Reports Published online 26 March 2013; doi: 10.1136/bcr-2012-007463)

An earlier study by the same doctor (Dr. Julien Freitag), which was also published in the “British Medical Journal”, used PAPRP on a healthy 38 year old man with traumatic chondral lesion of the left knee following a basketball injury. The patient experienced functional improvement within 2 weeks of commencing treatment and a perceived 100% improvement at Week 15. No complications were noted. (BMJ Case Reports Published Online: 17 December 2012; doi: 10.1136/bcr-2012-006858)

The forthcoming 40 patient clinical trial using PAPRP is now being undertaken by Dr. Julien Freitag on patients with knee osteoarthritis and knee joint pain. These conditions are normally difficult to treat - and major causes of disability and chronic pain amongst millions of people.

More information from http://www.adistem.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10940829.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Going a step Further: Phase IV and Post-Marketing Observational Studies add Value to new Therapies, life Science Webinar Hosted by Xtalks
2. Prova Education Hires Oncology Expert Alana Brody to Further Expand its Oncology Education and Opportunities
3. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
4. Medifirst Solutions, Inc. Announces Further Update To Shareholders
5. Probiotic Action Announces Further Exploration of Probiotics for Acne with New Information from the LA Times
6. Dr. Carlos Szajnert, Announced today his Commitment to Further Educate his Patients on the Benefits of Cord Blood Stem Cells
7. UCLA researchers further refine NanoVelcro device to grab single cancer cells from blood
8. Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria
9. China Cord Blood Corporation to Further Consolidate its Corporate Structure
10. OxThera Raises Capital for Further Clinical Development of Oxabact(R)
11. China Cord Blood Corporation and Golden Meditech Holdings Limited Enter into Convertible Note Financing to Further Expand Cord Blood Banking Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017  UBM and the Massachusetts ... their extended partnership and the third annual Massachusetts Medtech ... the 21 st Annual MassMEDIC Conference held ... May 3-4, 2017. MassMEDIC will ... (ADVAMED) President and CEO, Scott Whitaker , ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
(Date:3/22/2017)... 2017 /PRNewswire/ - FACIT announced a seed stage ... a start-up created by FACIT focused on developing ... combined with non-dilutive capital, achieves a targeted $3.0M ... enables Propellon to accelerate the nomination of a ... and/or entering a strategic partnership for clinical trials ...
(Date:3/22/2017)... ... March 21, 2017 , ... Premier executive recruitment firm, Slone Partners, ... Firm by Hunt Scanlon Media. , Hunt Scanlon Media is one of ... referenced global news source in the human capital sector. , “It is a great ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Who risk ... lawsuits? Download the full report: https://www.reportbuyer.com/product/4313699/ ... THE FINGERPRINT SENSOR FIELD? Fingerprint sensors using capacitive ... The fingerprint sensor vendor Idex forecasts an increase of ... mobile devices and of the fingerprint sensor market between ...
(Date:3/1/2017)... Mass. , March 1, 2017  Aware, Inc. ... services, announced that Richard P. Moberg has ... and co-President and Chief Financial Officer and Treasurer of ... continue to serve as a member of the Board ... Russell , Aware,s co-Chief Executive Officer and co-President, General ...
(Date:2/28/2017)... February 28, 2017 News solutions for biometrics, ... ... from 14 to 16 March, Materna will present its ... how seamless travel is a real benefit for passengers. To ... to their passenger touch point solutions to take passengers through the ...
Breaking Biology News(10 mins):